Perspective Therapeutics Inc. is a leading biotechnology firm dedicated to pioneering next-generation radiopharmaceuticals aimed at combating cancer. By leveraging advanced radioisotope technologies, the company is committed to improving treatment efficacy for patients facing diverse malignancies. With a focus on enhancing patient outcomes, Perspective Therapeutics is strategically positioned to meet the rising demand for targeted cancer therapies. The company benefits from a highly skilled leadership team and robust partnerships, which collectively bolster its prospects for delivering transformative innovations in oncology.

NYSE MKT

USA

HEALTHCARE

MEDICAL DEVICES

2401 ELLIOTT AVENUE, SEATTLE, WA, UNITED STATES, 98121

December

$632 Million

-$91.7 Million

0.0

-1.51

$0.00

0.0%

1.786